223 related articles for article (PubMed ID: 11217534)
1. "Postpsychotic depression" and residual schizophrenia in a mental health hospital.
Mauri MC; Laini V; Barone R; Clemente A; Volonteri LS; Cerveri G; Steinhilber C; Fornier M
Encephale; 2000; 26(6):21-6. PubMed ID: 11217534
[TBL] [Abstract][Full Text] [Related]
2. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
[TBL] [Abstract][Full Text] [Related]
3. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
5. Do neuroleptics cause depression?
Roy A
Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
Poyurovsky M; Faragian S; Shabeta A; Kosov A
Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
[TBL] [Abstract][Full Text] [Related]
7. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
[TBL] [Abstract][Full Text] [Related]
8. Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
Siris SG; Rifkin AE; Reardon GT
J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064
[TBL] [Abstract][Full Text] [Related]
9. What is the schizophrenic patients' level of information about their disease and their treatment?
Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
Encephale; 2000 Oct; 26 Spec No 1():15-22. PubMed ID: 11294058
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenic patients before and after HIV infection: a case-control study.
Mauri MC; Fabiano L; Bravin S; Ricci C; Invernizzi G
Encephale; 1997; 23(6):437-41. PubMed ID: 9488926
[TBL] [Abstract][Full Text] [Related]
11. [What information do patients with schizophrenia have about their illness and treatment?].
Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
13. Stability of the postpsychotic depression syndrome.
Siris SG; Rifkin A; Reardon GT; Doddi SR; Strahan A; Hall KS
J Clin Psychiatry; 1986 Feb; 47(2):86-8. PubMed ID: 3944070
[TBL] [Abstract][Full Text] [Related]
14. Frequency and differential diagnosis of depressive syndromes in schizophrenia.
Martin RL; Cloninger CR; Guze SB; Clayton PJ
J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255
[TBL] [Abstract][Full Text] [Related]
15. Depression in schizophrenia - literature overview.
Avgustin B
Psychiatr Danub; 2009 Sep; 21 Suppl 1():93-7. PubMed ID: 19789490
[No Abstract] [Full Text] [Related]
16. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
[TBL] [Abstract][Full Text] [Related]
17. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
Bobes J; Fillat O; Arango C
Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
[TBL] [Abstract][Full Text] [Related]
19. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
[TBL] [Abstract][Full Text] [Related]
20. Correlates of self-harm behaviour in acutely ill patients with schizophrenia.
Simms J; McCormack V; Anderson R; Mulholland C
Psychol Psychother; 2007 Mar; 80(Pt 1):39-49. PubMed ID: 17346379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
